Payments to Acquire Property, Plant, and Equipment of SANGAMO THERAPEUTICS, INC from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
SANGAMO THERAPEUTICS, INC annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • SANGAMO THERAPEUTICS, INC Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $0, a 100% decline year-over-year.
  • SANGAMO THERAPEUTICS, INC annual Payments to Acquire Property, Plant, and Equipment for 2024 was $267,000, a 99% decline from 2023.
  • SANGAMO THERAPEUTICS, INC annual Payments to Acquire Property, Plant, and Equipment for 2023 was $21,155,000, a 4.9% increase from 2022.
  • SANGAMO THERAPEUTICS, INC annual Payments to Acquire Property, Plant, and Equipment for 2022 was $20,171,000, a 13% decline from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

SANGAMO THERAPEUTICS, INC Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $267,000 -$20,888,000 -99% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $21,155,000 +$984,000 +4.9% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $20,171,000 -$3,107,000 -13% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 $23,278,000 +$8,564,000 +58% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
2020 $14,714,000 -$5,961,000 -29% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $20,675,000 -$22,390,000 -52% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $43,065,000 +$39,314,000 +1048% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $3,751,000 +$3,019,000 +412% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $732,000 -$1,679,000 -70% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $2,411,000 +$1,790,000 +288% 01 Jan 2015 31 Dec 2015 10-K 18 Feb 2016 2015 FY
2014 $621,000 +$189,000 +44% 01 Jan 2014 31 Dec 2014 10-K 18 Feb 2016 2015 FY
2013 $432,000 -$291,000 -40% 01 Jan 2013 31 Dec 2013 10-K 18 Feb 2016 2015 FY
2012 $723,000 +$147,000 +26% 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015 2014 FY
2011 $576,000 -$119,000 -17% 01 Jan 2011 31 Dec 2011 10-K 24 Feb 2014 2013 FY
2010 $695,000 01 Jan 2010 31 Dec 2010 10-K 26 Feb 2013 2012 FY

SANGAMO THERAPEUTICS, INC Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 -$10,200,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q1 2023 $10,200,000 +$7,361,000 +259% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $2,839,000 -$5,111,000 -64% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $7,950,000 +$4,175,000 +111% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $3,775,000 -$2,202,000 -37% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $5,977,000 +$3,361,000 +128% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $2,616,000 +$2,148,000 +459% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $468,000 +$216,000 +86% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $252,000 -$832,000 -77% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $1,084,000 +$958,000 +760% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q1 2014 $126,000 +$58,000 +85% 01 Jan 2014 31 Mar 2014 10-Q 28 Apr 2015 2015 Q1
Q1 2013 $68,000 -$150,000 -69% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014 2014 Q1
Q1 2012 $218,000 +$108,000 +98% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q1 2011 $110,000 01 Jan 2011 31 Mar 2011 10-Q 07 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.